Increased proliferation of endothelial cells with overexpression of soluble TNF-α receptor I gene

Atherosclerosis

Volumn 162, Issue 1, 2002, Pages 77-84

  Sugano, Masahiro ^a   Tsuchida, Keiko ^a   Tomita, Hideharu ^a   Makino, Naoki ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Endothelial cell proliferation; Endothelial cells; Soluble TNF receptor I; TNF

Indexed keywords

LIPOFECTIN; MESSENGER RNA; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; VASCULOTROPIN;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; SMOOTH MUSCLE FIBER; SOLUBILITY; UMBILICAL VEIN; VASCULAR DISEASE;

ACETYLCYSTEINE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 0036223848     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00684-0     Document Type: Article

References (30)

1. Therapeutic angiogenesis: A single intraarterial bonus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
2. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis
3. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease
4. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
5. Vascular endothelial growth factor inhibits endothelial cell apoptosis induced by tumor necrosis factor-α: Balance between growth and death signals
6. Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-α in cultured human vascular endothelial cells
7. Improvement of the immune system in human atherogenesis: Current knowledge and unanswered question
8. Expression of tumor necrosis factor alpha and accumulation of fibronectin in coronary artery restenotic lesion retrieved by atherectomy
9. Proliferatiing arterial smooth muscle cells after balloon injury express TNF-α but not interleukin-1 or basic fibriblast growth factor
10. Attenuation of skeletal muscle ischemia/reperfusion injury by inhibition of tumor necrosis factor
11. Purification and biologic characterization of a specific tumor necrosis factor-α inhibitor
12. Apoptosis-inducing agent cause rapid shedding of tumor necrosis factor 1 (TNFR1)
13. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death
14. Multifaceted inhibition of anti-tumor immune mechanisms by solublr tumor necrosis factor receptor type I
15. Gene transfer into rat heart-derived endothelial cells
16. Secretion of preβ HDL increases with the suppression of cholesteryl ester transfer protein in Hep G2 cells
17. Bioflavonoid quercetin inhibits interleukin-1-induced transcriptional expression of monocyte chemoattractant protein-1 in glomerular cells via suppression of nuclear factor-κB
18. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells
19. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy
20. Potential role of hepatocyte growth factor in the maintenance of renal structure: Anti-apoptotic action of HGF on epithelial cells
21. Detection and localization of tumor necrosis factor-alpha in WHHL rabbit arteries
22. Evidence for involvement of endothelial cell integrin alpha Vbeta 3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma
23. VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo
24. Restoration of E2F expression rescues vascular endothelial cell from tumor necrosis factor-α-induced apoptosis
25. Progressive growth of human papillomavirus type 16-transformed keratinocytes is associated with an increased release of soluble tumor necrosis factor (TNF) receptor
26. Suppression of TNF-alpha-induced apoptosis by NF-κB
27. Chemokines and their role in cardiovascular diseases
28. Activation of NF-κB is essential but not sufficient to stimulate mitogenesis of vascular smooth muscle cells
29. Vasculogenesis
30. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55